Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuan An

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
Rheumatology (Oxford, England)|March 11, 2021
Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Vera Golder, et al.
Advances in Rheumatology (London, England)|May 9, 2024
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort studyRicardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, et al.
Nature Medicine|August 9, 2016
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosusJing He, Xia Zhang, Yunbo Wei, et al.
International Journal of Rheumatic Diseases|November 7, 2018
Development of the Asia Pacific Lupus Collaboration cohortRangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
Arthritis Care & Research|July 1, 2021
Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort StudyRangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, et al.
Clinical Rheumatology|November 30, 2018
Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled studyYuan An, Yunshan Zhou, Liqi Bi, et al.
Arthritis Research & Therapy|March 15, 2022
'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Alberta Hoi, et al.
International Journal of Rheumatic Diseases|August 26, 2020
COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus CollaborationJiacai Cho, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Rheumatology (Oxford, England)|May 19, 2023
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoringAi Li Yeo, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2022
Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective StudyKathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Rheumatology (Oxford, England)|March 11, 2021
Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Vera Golder, et al.
Advances in Rheumatology (London, England)|May 9, 2024
Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort studyRicardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, et al.
Nature Medicine|August 9, 2016
Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosusJing He, Xia Zhang, Yunbo Wei, et al.
International Journal of Rheumatic Diseases|November 7, 2018
Development of the Asia Pacific Lupus Collaboration cohortRangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
Arthritis Care & Research|July 1, 2021
Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort StudyRangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, et al.
Clinical Rheumatology|November 30, 2018
Combined immunosuppressive treatment (CIST) in lupus nephritis: a multicenter, randomized controlled studyYuan An, Yunshan Zhou, Liqi Bi, et al.
Arthritis Research & Therapy|March 15, 2022
'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort studyRangi Kandane-Rathnayake, Worawit Louthrenoo, Alberta Hoi, et al.
International Journal of Rheumatic Diseases|August 26, 2020
COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus CollaborationJiacai Cho, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Rheumatology (Oxford, England)|May 19, 2023
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoringAi Li Yeo, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2022
Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective StudyKathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, et al.
Pageof 21